Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Auxly Cannabis GroupCBWTF -3.12%36 Return-on-Tangible-Asset is 5.61% as of Mar. 2026. GuruFocus rates CBWTF with a GF Score™ of 36/100 and a GF Value™ of $0.50 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Auxly Cannabis Group ranks better than 86.71% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Auxly Cannabis Group's annualizedNet Income for the quarter that ended in Mar. 2026 was $10.1 Mil. Auxly Cannabis Group's average total tangible assets for the quarter that ended in Mar. 2026 was $180.0 Mil. Therefore, Auxly Cannabis Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 5.61%.
The historical rank and industry rank for Auxly Cannabis Group's Return-on-Tangible-Asset or its related term are showing as below:
CBWTF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -61.31 Med: -30.63 Max: 17.62
Current: 13.75
During the past 13 years, Auxly Cannabis Group's highest Return-on-Tangible-Asset was 17.62%. The lowest was -61.31%. And the median was -30.63%.
CBWTF's Return-on-Tangible-Asset is ranked better than 86.71% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 3.14
vs CBWTF: 13.75
Auxly Cannabis Group (OTCPK:CBWTF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Auxly Cannabis Group Return-on-Tangible-Asset Related Terms
Auxly Cannabis Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Auxly Cannabis Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auxly Cannabis Group Return-on-Tangible-Asset Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Auxly Cannabis Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Auxly Cannabis Group Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Auxly Cannabis Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Auxly Cannabis Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 5.61% mean?
Auxly Cannabis Group (CBWTF) has a Return-on-Tangible-Asset of 5.61% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Auxly Cannabis Group and its competitors. According to the industry distribution chart, Auxly Cannabis Group ranks #134 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 13.3%.
Is Auxly Cannabis Group's Return-on-Tangible-Asset too high?
Auxly Cannabis Group's current Return-on-Tangible-Asset is 5.61%. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.14. Auxly Cannabis Group's value of 5.61% is 78.7% above this industry median. Based on the distribution chart, Auxly Cannabis Group ranks #134 out of 1008 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Auxly Cannabis Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's Return-on-Tangible-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Auxly Cannabis Group ranks #134 out of 1008 companies for Return-on-Tangible-Asset. This places Auxly Cannabis Group in the top 13% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.14. Auxly Cannabis Group's value of 5.61% is 78.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.14, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Auxly Cannabis Group's current Return-on-Tangible-Asset of 5.61% is 78.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Auxly Cannabis Group and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Auxly Cannabis Group's current Return-on-Tangible-Asset is 5.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.50, compared to a current price of $1.79 — trading 257% above its estimated fair value. The current Return-on-Tangible-Asset is 5.61% and 78.7% above the Drug Manufacturers industry median of 3.14. Auxly Cannabis Group's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current Return-on-Tangible-Asset is 5.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?
Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued.
The current stock price of $1.79 is trading 257% above its estimated GF Value™ of $0.50.
GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.
Key valuation signals for CBWTF:
Return-on-Tangible-Asset: 5.61%
GF Value™: $0.50 vs. price of $1.79 (257% above fair value)
Industry Position: 78.7% above the Drug Manufacturers median (#134 of 1008)
No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
36GF Score
Get the complete analysis for CBWTF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBWTF has been successfully added to your 
